1. Home
  2. MNMD vs GES Comparison

MNMD vs GES Comparison

Compare MNMD & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$12.64

Market Cap

960.2M

Sector

Health Care

ML Signal

HOLD

Logo Guess? Inc.

GES

Guess? Inc.

HOLD

Current Price

$16.99

Market Cap

872.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNMD
GES
Founded
2019
1981
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
872.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MNMD
GES
Price
$12.64
$16.99
Analyst Decision
Strong Buy
Buy
Analyst Count
9
5
Target Price
$25.78
$19.88
AVG Volume (30 Days)
1.6M
558.5K
Earning Date
11-06-2025
11-25-2025
Dividend Yield
N/A
5.32%
EPS Growth
N/A
N/A
EPS
N/A
1.07
Revenue
N/A
$3,144,417,000.00
Revenue This Year
N/A
$8.97
Revenue Next Year
N/A
$4.07
P/E Ratio
N/A
$15.79
Revenue Growth
N/A
6.44
52 Week Low
$4.70
$8.48
52 Week High
$14.43
$17.15

Technical Indicators

Market Signals
Indicator
MNMD
GES
Relative Strength Index (RSI) 56.21 51.88
Support Level $11.80 $16.92
Resistance Level $13.45 $17.15
Average True Range (ATR) 0.73 0.11
MACD 0.13 -0.01
Stochastic Oscillator 73.54 46.77

Price Performance

Historical Comparison
MNMD
GES

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: